healnet
- North America > United States (0.67)
- Europe > United Kingdom > England > Cambridgeshire > Cambridge (0.14)
- North America > Canada > Quebec > Montreal (0.04)
- Research Report > New Finding (0.93)
- Research Report > Experimental Study (0.93)
- Health & Medicine > Therapeutic Area > Oncology (1.00)
- Health & Medicine > Pharmaceuticals & Biotechnology (1.00)
- Health & Medicine > Diagnostic Medicine (1.00)
HEALNet: Multimodal Fusion for Heterogeneous Biomedical Data
Technological advances in medical data collection, such as high-throughput genomic sequencing and digital high-resolution histopathology, have contributed to the rising requirement for multimodal biomedical modelling, specifically for image, tabular and graph data. Most multimodal deep learning approaches use modality-specific architectures that are often trained separately and cannot capture the crucial cross-modal information that motivates the integration of different data sources.
- North America > United States (0.67)
- Europe > United Kingdom > England > Cambridgeshire > Cambridge (0.14)
- North America > Canada > Quebec > Montreal (0.04)
- Research Report > New Finding (0.93)
- Research Report > Experimental Study (0.93)
- Health & Medicine > Therapeutic Area > Oncology (1.00)
- Health & Medicine > Pharmaceuticals & Biotechnology (1.00)
- Health & Medicine > Diagnostic Medicine (1.00)
HEALNet: Multimodal Fusion for Heterogeneous Biomedical Data
Technological advances in medical data collection, such as high-throughput genomic sequencing and digital high-resolution histopathology, have contributed to the rising requirement for multimodal biomedical modelling, specifically for image, tabular and graph data. Most multimodal deep learning approaches use modality-specific architectures that are often trained separately and cannot capture the crucial cross-modal information that motivates the integration of different data sources. This paper presents the Hybrid Early-fusion Attention Learning Network (HEALNet) – a flexible multimodal fusion architecture, which: a) preserves modality-specific structural information, b) captures the cross-modal interactions and structural information in a shared latent space, c) can effectively handle missing modalities during training and inference, and d) enables intuitive model inspection by learning on the raw data input instead of opaque embeddings. We conduct multimodal survival analysis on Whole Slide Images and Multi-omic data on four cancer datasets from The Cancer Genome Atlas (TCGA). HEALNet achieves state-of-the-art performance compared to other end-to-end trained fusion models, substantially improving over unimodal and multimodal baselines whilst being robust in scenarios with missing modalities.
- Health & Medicine > Pharmaceuticals & Biotechnology (0.74)
- Health & Medicine > Therapeutic Area > Oncology (0.63)
HEALNet -- Hybrid Multi-Modal Fusion for Heterogeneous Biomedical Data
Hemker, Konstantin, Simidjievski, Nikola, Jamnik, Mateja
Technological advances in medical data collection such as high-resolution histopathology and high-throughput genomic sequencing have contributed to the rising requirement for multi-modal biomedical modelling, specifically for image, tabular, and graph data. Most multi-modal deep learning approaches use modality-specific architectures that are trained separately and cannot capture the crucial cross-modal information that motivates the integration of different data sources. This paper presents the Hybrid Early-fusion Attention Learning Network (HEALNet): a flexible multi-modal fusion architecture, which a) preserves modality-specific structural information, b) captures the cross-modal interactions and structural information in a shared latent space, c) can effectively handle missing modalities during training and inference, and d) enables intuitive model inspection by learning on the raw data input instead of opaque embeddings. We conduct multi-modal survival analysis on Whole Slide Images and Multi-omic data on four cancer cohorts of The Cancer Genome Atlas (TCGA). HEALNet achieves state-of-the-art performance, substantially improving over both uni-modal and recent multi-modal baselines, whilst being robust in scenarios with missing modalities.
- North America > United States (0.14)
- North America > Canada > Quebec > Montreal (0.04)
- Europe > United Kingdom > England > Cambridgeshire > Cambridge (0.04)
- Health & Medicine > Therapeutic Area > Oncology (1.00)
- Health & Medicine > Pharmaceuticals & Biotechnology (1.00)